Replies to post #185113 on Biotech Values

[vinmantoo]

Well said jq1234.

[zipjet]

I think you are missing my point.

I suspect there was a negotiation between ESRX and ABBV and GILD. ESRX would want competition between the sellers (GILD too) in order to get the lowest price.

So I am saying that one of two things happened:

1 - GILD priced/discounted aggressively and ABBV needed to go even deeper to ink the deal; or

2 - ABBV fearing GILD was aggressive, took a bigger hit in the negotiations than they needed to do.

ABBV should have been in the stronger position than GILD going into the negotiation with ESRX because of the anger expressed against GILD by ESRX.

[jbog]

jq1234,

What's your impression of Express's actions? In the future are we going to pick our Insurance policy/benefit manager on a yearly basis depending on what brand drugs they cover? They didn't seem to care if the Abbvie drugs were better/equal or inferior, simply because the price was right.

Will the express group provide Novo only diabetes medicine while the CVS group will be limited to Lilly drugs? Is that where we're headed.

[north40000]

"This episode shows many free marketers actually want to preserve monopoly rather than true free market."

With patent system, do you really believe there is a free market rather than the exclusive right[temporary monopoly] conferred by a patent grant?

I realize my question makes as much sense as your statement.